1Department of Medicine, University of Saskatchewan, Regina, Canada
2Whitman-Walker Institute, Washington DC, US
3HIV Unit. Infectious Diseases Service. Hospital Clínic. Barcelona, Spain
4Orlando Immunology Center, Orlando, FL
5Ian Charleson Day Centre, London, UK
6University of Paris Diderot, Hôpital Saint-Louis, Paris, France
7Chelsea and Westminster Hospital, London, UK
8Merck & Co., Inc., Kenilworth NJ, USA.
Corresponding author: Hedy Teppler
Conflicts of interest: AR, VT, DH, SK, PS, GJH, CH, CB, and HT are employees of Merck & Co., Inc., Kenilworth, NJ, USA, and may own stock and/or hold stock options in the Company. JM has received honoraria from Gilead Sciences, Inc, Foster City, CA, and Merck, Sharp, & Dohme Corp, a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA for participating to advisory boards and has received a research grant from Gilead Sciences, Inc.
Source of Funding: Merck, Sharp, & Dohme Corp, a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA, provided financial support for the study.
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.